BioNTech SE (BNTX)
112.82
-3.75
(-3.22%)
USD |
NASDAQ |
Aug 24, 16:00
113.17
+0.35
(+0.31%)
After-Hours: 20:00
BioNTech Debt to Equity Ratio : 0.0178 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0178 |
| March 31, 2026 | 0.0162 |
| December 31, 2025 | 0.0139 |
| September 30, 2025 | 0.0133 |
| June 30, 2025 | 0.0146 |
| March 31, 2025 | 0.0155 |
| December 31, 2024 | 0.0131 |
| September 30, 2024 | 0.0127 |
| June 30, 2024 | 0.0133 |
| March 31, 2024 | 0.0118 |
| December 31, 2023 | 0.0108 |
| September 30, 2023 | 0.0102 |
| June 30, 2023 | 0.0103 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0104 |
| December 31, 2022 | 0.0106 |
| September 30, 2022 | 0.0149 |
| June 30, 2022 | 0.0142 |
| March 31, 2022 | 0.0117 |
| December 31, 2021 | 0.0253 |
| September 30, 2021 | 0.0329 |
| June 30, 2021 | 0.0468 |
| March 31, 2021 | 0.101 |
| December 31, 2020 | 0.1751 |
| September 30, 2020 | 0.1926 |
| June 30, 2020 | 0.1211 |
| March 31, 2020 | 0.1537 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Moderna, Inc. | 0.1904 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 0.0359 |
| NuCana Plc | 0.0332 |
| MediGene AG | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 23.26B |
| Total Liabilities (Quarterly) | 2.956B |
| Shareholders Equity (Quarterly) | 20.30B |
| Current Ratio | 7.848 |
| Net Debt Paydown Yield | -0.04% |